Magnetic nanoparticles to improve the contrast of Magnetic Resonance Imaging
Archives of Medical Laboratory Sciences,
Vol. 5 No. 1 (2019),
29 March 2020
https://doi.org/10.22037/amls.v5i1.28475
Abstract
Earlier detection of diseases reduces the mortality rate. So the development of better screening techniques could be considered as a main topic of interest. In non-invasive medical imaging, specifically in Magnetic Resonance Imaging (MRI), conventional contrast agents do not have a good performance in imaging of some fine parts. The prosperity of preclinical researches in oncology that purpose at developing and evaluating curative strategies on samples, requires effective new functionalized contrast agents for portrayal tumor growth, monitoring the trace of a treatment and/or inducing the demolition of cancerous tumors. This study was performed by searching Nanotechnology, Molecular imaging, magnetic nanoparticles, and contrast agent nanoparticles keywords in Google scholar, Science direct, PubMed and Scopus websites in terms of content. We reviewed the recent studies about development of nanoparticles as contrast agents for medical imaging because they have a longer vascular half-life than molecular contrast agents. It could be indicate that nanoparticles are important items in increasing the contrast of the images so that even reducing the size of the magnetic nanoparticles escalates the contrast and half-life of the particles. Particles with a diameter of 10 nm have a greater half-life than particles with a diameter of 30 nm or larger. It was also found that to removing material defects or improve their biocompatibility; particles should be covered with other materials or doped with metals.
- Magnetic Resonance Imaging
- magnetic iron oxide
- contrast agents nanoparticle
How to Cite
References
Mankoff DA. A definition of molecular imaging. J Nucl Med. 2007;48(6):18N.
SHI Y. Superparamagnetic Nanoparticle for magnetic Resonance Imaging(MRI)Diagnosis. School of Chemical Engineering.(2006)
Varadan VK, Chen L, Xie J. NANOMEDICINEDESIGN AND APPLICATIONS OFMAGNETIC NANOMATERIALS,NANOSENSORS AND NANOSYSTEMS. A John Wiley and Sons, Ltd, Publication. 2008
Zachary R. Stephen, F. M. K., and Miqin Zhang. Magnetite nanoparticles for medical MR imaging. Department of Materials Science and Engineering 14 (2011).
Labhasetwar V, Leslie-Pelecky D, Jain T. Multifunctional Magnetic Nanoparticles for Imaging and Drug Delivery. The Science of innovation.( 2007).
CA Mirkin and CM Niemeyer. Nanobiotechnology, I. Wiley-VCH, Weinheim, As i an J 2, 1363 (2007).
Oghabian MA, Guiti M, Haddad P, Gharehaghaji N, Saber R, Alam NR, et al. Detection sensitivity of MRI using ultra-small super paramagnetic iron oxide nano-particles (USPIO) in biological tissues. EMBS 2006 Jun, 28th Annual International Conference of the IEEE 5625-6
Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006 Dec;58:1471–1504.
Omid Veiseh, Jonathan Gunn, and Miqin Zhang. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010 Mar 8; 62(3): 284–304
Young‐Wook, Jun Jae‐Hyun Lee, Jinwoo Cheon. Nanoparticle Contrast Agents for Molecular Magnetic Resonance Imaging. Nanobiotechnology II, 01/01/2007
Cindy S, Lionel M, Timo G, Paula H, Thomas B, A Robin P.et al. Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans. Int J Nanomedicine. 2016; 11: 5883–5896.
Reimer P, Bremer C, Allkemper T, Engelhardt M, Mahler M, Ebert W. et al. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebocontrolled clinical phase I study. Radiology. 2004 May;231:474–81.
Schnorr J, Wagner S, Abramjuk C, Wojner I, Schink T, Kroencke TJ. et al. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetatedimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs. Invest Radiol. 2004 Sep;39:546–53.
Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S. et al. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosvesettrisodium in pigs. Rofo. 2012 Feb;184(2):105–12.
Nahideh Gharehaghaji, Mahmood Nazarpoor, and Hodaiseh Saharkhiz. Effect of iron oxide nanoparticles coating type on the relationship between nanoparticles concentration and signal intensity in inversion recovery T1-weighted MRI. 2015 May 6; 29: 211.
Debora B, Ulrich J. Aschauer, Jessica A. M. Bastiaansen, Matthias S, Heinrich H, and Marijana Mionić Ebersold. Versatility of Pyridoxal Phosphate as a Coating of Iron Oxide Nanoparticles. Nanomaterials (Basel). 2017 Aug; 7(8): 202
Herman DAJ, Ferguson P, Cheong S, Hermans IF, Ruck BJ, et al. (2011) Hot-Injection Synthesis of Iron/Iron Oxide Core/Shell Nanoparticles for T2 Contrast Enhancement in Magnetic Resonance Imaging. Chem Comm 47: 9221–9223.
Cheong S, Ferguson P, Hermans IF, Jameson GNL, Prabakar S, et al. (2012) Synthesis and Stability of Highly Crystalline and Stable Iron/Iron Oxide Core/Shell Nanoparticles for Biomedical Applications. ChemPlusChem 77: 135–140.
Tiefenauer LX, Tschirky A, Kühne G, Andres RY (1996) In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn. Reson. Imaging 14: 391–402.
Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S.. Properties Evaluation of a New MRI Contrast Agent Based on Gd-Loaded Nanoparticles Biol Trace Elem Res. 2010 Dec;137(3):324-34 François Lux, Lucie Sancey, Andrea Bianchi, Yannick Crémillieux, Stéphane Roux& Olivier Tillement. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine. 25 Feb 2015.
Lisa M, Manus†Daniel J,Mastarone Emily A, Waters Xue-Qing Zhang.et al. Gd(III)-Nanodiamond Conjugates for MRI Contrast Enhancement. Nano Lett. 2010, 10, 2, 484-489
Joan Estelrich, María Jesús Sánchez-Martín, and Maria Antònia Busquets. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. International Journal of Nanomedicine.2015. 10:1727-1741.
Ananta JS, Godin B, Sethi R, Moriggi L, Liu X, Serda RE, Krishnamurthy R, Muthupillai R, Bolskar RD, Helm L, Ferrari M. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nature nanotechnology. 2010 Nov 1;5(11):815-21..
Ahre n M, Selega rd L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Langmuir. 2010 Mar 24;26(8):5753-62.
Christophe Alric , Jacqueline Taleb , Géraldine Le Duc , Claire Billotey. Gadolinium chelate coated Gold nanoparticles as contrast agents.J. AM. CHEM. SOC.2008. VOL. 130, NO. 18
Yi Hou, Ruirui Qiao, Fang Fang, Xuxia Wang, Chengyan Dong, Kan Liu, et al. NaGdF4 Nanoparticle-Based Molecular Probes for Magnetic Resonance Imaging of Intraperitoneal Tumor Xenografts in Vivo. ACS Nano, 2013, 7 (1), pp 330–338
Anubhab Mukherjee,1,2 Ariana K Waters,1,2 Pranav Kalyan. Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. 2019 Mar 19. doi: 10.2147/IJN.S198353
- Abstract Viewed: 169 times
- PDF Downloaded: 106 times